Back to All Events

Pharmaceutical Science and Clinical Pharmacology Advisory Committee

The committee will discuss the following topics: (1) approaches to evaluate the effect of renal impairment on drug exposure, and (2) best practice considerations for translating pharmacokinetic (PK) information into dose individualization instructions.